Risk Factors for Linezolid Resistance in Staphylococcus Aureus

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00519025

Enrollment

360

Registered

2007-08-21

Start date

2007-08-31

Completion date

2017-06-30

Last updated

2018-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Linezolid Resistance, Staphylococcus Aureus

Keywords

Linezolid, Staphylococcus Aureus, Infections

Brief summary

Detailed description

This is a retrospective chart review study. The proposed study aims to document the risk factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be assessed. This research is important because identification of risk factors may allow earlier initiation of appropriate therapy in patients infected with these bacteria. Additionally, we will identify whether horizontal spread is responsible for this increasing trend.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients with linezolid resistance to staphylococcus aureus

Exclusion criteria

* those that don't meet entry criteria

Countries

United States

Outcome results